Asia Pacific Cryoablation Probes Market Size, Share, and COVID-19 Impact Analysis, By Application (Cardiac Arrhythmias, Oncology, Dermatology, and Others), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers (ASCs), and Others), and Asia Pacific Cryoablation Probes Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Cryoablation Probes Market Insights Forecasts to 2035

• The Asia Pacific Cryoablation Probes Market Size was Estimated at USD 47.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 19.05% from 2025 to 2035
• The Asia Pacific Cryoablation Probes Market Size is Expected to Reach USD 323.5 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the Asia Pacific Cryoablation Probes Market Size is Anticipated to Reach USD 323.5 Million by 2035, Growing at a CAGR of 19.05% from 2025 to 2035. The growing incidence of cancer and need for effective minimally invasive treatments are driving the cryoablation probes market in the Asia Pacific region.

Market Overview

The Asia Pacific cryoablation probes market encompasses the development, manufacturing, and sale of probes used for destroying abnormal tissues by freezing them. In cryoablation, the high-pressure argon gas or liquid nitrogen is passed through a thin channel in the cryo needle or probe and released at its tip, causing a sudden drop in the pressure of the argon gas, which creates a cooling of minus 40-140 degrees in the tissue, resulting in widespread tissue death due to formation of ice crystals. Cryoablation is preferably used due to its shorter recovery time, fewer complications, and better cosmetic results as compared to traditional surgery. Continuous advancement in probe design, including the imaging technologies and cryogen control systems for enhancing precision and safety, is driving its adoption in clinical settings. With the increasing healthcare infrastructure, the adoption of advanced therapies is providing growth opportunities in the cryoablation probes market.

Report Coverage

This research report categorizes the market for the Asia Pacific cryoablation probes market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific cryoablation probes market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific cryoablation probes market.

Driving Factors

The market for Asia Pacific cryoablation probes is primarily driven by the growing prevalence of cancer. Cancer is a significant public health threat in Asia, driving the demand for cancer management and control. Further, an increasing cancer awareness and availability of affordable & cost-effective therapeutics are contributing to driving the market demand for cryoablation probes. The increasing preference for minimally invasive techniques is driving the demand for cryoablation probes, promoting the market growth.

Restraining Factors

The increased device cost and limited accessibility owing to insufficient infrastructure and a lack of awareness about cryoablation are restraining the cryoablation probes market. Further, lengthy regulatory approval procedures are challenging the market growth.

Market Segmentation

The Asia Pacific cryoablation probes market share is classified into application and end use.

• The cardiac arrhythmias segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific cryoablation probes market is segmented by application into cardiac arrhythmias, oncology, dermatology, and others. Among these, the cardiac arrhythmias segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. By disabling heart cells that create irregular heartbeat, cryoablation aids in restoring the heart rhythm. An increasing patient pool and continuous advancement in cryoablation technology are driving the cryoablation probes market.

• The hospitals segment dominated the cryoablation probes market in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific cryoablation probes market is segmented by end use into hospitals, specialty clinics, ambulatory surgery centers (ASCs), and others. Among these, the hospitals segment dominated the cryoablation probes market in 2024 and is expected to grow at a significant CAGR during the forecast period. Hospitals are the central hub for complex medical procedures, possessing extensive infrastructure and specialized facilities like operating rooms, interventional suites, and dedicated imaging departments. The increasing presence of oncology hospitals with increased dedication to offering innovative cancer treatment, focusing on patient comfort and recovery, is promoting the cryoablation probes market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific cryoablation probes market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• AtriCure Inc.
• Boston Scientific Corporation
• Medtronic PLC
• CooperSurgical, Inc.
• Varian (a Siemens Healthineers Company)
• IceCure Medical
• Bruker Corp
• Erbe Elektromedizin GmbH
• Micro Port Scientific Corporation
• Others

Recent Developments:

• In February 2025, IceCure Medical Ltd. announced it had filed for regulatory approval with the Medical Device Division ("AMAR") of Israel's Ministry of Health for its next-generation single cryoprobe cryoablation system, the XSense System and CryoProbes.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Cryoablation Probes Market based on the below-mentioned segments:

Asia Pacific Cryoablation Probes Market, By Application

• Cardiac Arrhythmias
• Oncology
• Dermatology
• Others

Asia Pacific Cryoablation Probes Market, By End Use

• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers (ASCs)
• Others